Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ArcelorMittal SA (MT) vs Summit Therapeutics Inc (SMMT) Price & Performance

ArcelorMittal SATrade
Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

ArcelorMittal SA vs Summit Therapeutics Inc — how do they compare? ArcelorMittal SA trades at $74.2 (market cap $55.88B), while Summit Therapeutics Inc trades at $15.35 (market cap $12.06B). The key difference: ArcelorMittal SA is far larger — about 4.6× Summit Therapeutics Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.

MTSMMT
Market Cap
$55.88B$12.06B
Sector
Basic MaterialsHealth
52-Week High
$75.35$26.98
52-Week Low
$32.44$12.55
Enterprise Value
$65.45B$11.39B
Dividend Yield
0.81%

Returns comparison

Trailing returns across standard periods

About ArcelorMittal SA

ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA

Read more on MT

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Read more on SMMT